⌘K

Login Start Free

Home/Filings/4/0001171843-21-008176

4//SEC Filing

Doyle Anthony 4

Accession 0001171843-21-008176

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 6:35 PM ET

Size

4.4 KB

Accession

0001171843-21-008176

Insider Transaction Report

Form 4

Period: 2021-11-23

BIOCRYST PHARMACEUTICALS INCBCRX

Chief Financial Officer

Transactions

Purchase
Common Stock
2021-11-23$12.48/sh+35,258$440,020→ 93,719 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001808688

Filing Metadata

Form type: 4
Filed: Nov 23, 7:00 PM ET
Accepted: Nov 24, 6:35 PM ET
Size: 4.4 KB

View on SEC.gov